Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Ancient convergent losses of Paraoxonase 1 yield potential risks for modern marine mammals.

Meyer WK, Jamison J, Richter R, Woods SE, Partha R, Kowalczyk A, Kronk C, Chikina M, Bonde RK, Crocker DE, Gaspard J, Lanyon JM, Marsillach J, Furlong CE, Clark NL.

Science. 2018 Aug 10;361(6402):591-594. doi: 10.1126/science.aap7714.

PMID:
30093596
2.

Subterranean mammals show convergent regression in ocular genes and enhancers, along with adaptation to tunneling.

Partha R, Chauhan BK, Ferreira Z, Robinson JD, Lathrop K, Nischal KK, Chikina M, Clark NL.

Elife. 2017 Oct 16;6. pii: e25884. doi: 10.7554/eLife.25884.

3.

Revisiting robustness and evolvability: evolution in weighted genotype spaces.

Partha R, Raman K.

PLoS One. 2014 Nov 12;9(11):e112792. doi: 10.1371/journal.pone.0112792. eCollection 2014.

4.

Buckysomes: New Nanocarriers for Anticancer Drugs.

Danila D, Golunski E, Partha R, McManus M, Little T, Conyers J.

J Pharm (Cairo). 2013;2013:390425. doi: 10.1155/2013/390425. Epub 2013 Feb 28.

5.

Dendro[C(60)]fullerene DF-1 provides radioprotection to radiosensitive mammalian cells.

Theriot CA, Casey RC, Moore VC, Mitchell L, Reynolds JO, Burgoyne M, Partha R, Huff JL, Conyers JL, Jeevarajan A, Wu H.

Radiat Environ Biophys. 2010 Aug;49(3):437-45. doi: 10.1007/s00411-010-0310-4. Epub 2010 Jun 27.

PMID:
20582595
6.

Biomedical applications of functionalized fullerene-based nanomaterials.

Partha R, Conyers JL.

Int J Nanomedicine. 2009;4:261-75. Review.

8.

Antioxidant single-walled carbon nanotubes.

Lucente-Schultz RM, Moore VC, Leonard AD, Price BK, Kosynkin DV, Lu M, Partha R, Conyers JL, Tour JM.

J Am Chem Soc. 2009 Mar 25;131(11):3934-41. doi: 10.1021/ja805721p.

PMID:
19243186
9.

Buckysomes: fullerene-based nanocarriers for hydrophobic molecule delivery.

Partha R, Mitchell LR, Lyon JL, Joshi PP, Conyers JL.

ACS Nano. 2008 Sep 23;2(9):1950-8. doi: 10.1021/nn800422k.

PMID:
19206436
10.

His-75 in proteorhodopsin, a novel component in light-driven proton translocation by primary pumps.

Bergo VB, Sineshchekov OA, Kralj JM, Partha R, Spudich EN, Rothschild KJ, Spudich JL.

J Biol Chem. 2009 Jan 30;284(5):2836-43. doi: 10.1074/jbc.M803792200. Epub 2008 Nov 17.

11.

An iodinated liposomal computed tomographic contrast agent prepared from a diiodophosphatidylcholine lipid.

Elrod DB, Partha R, Danila D, Casscells SW, Conyers JL.

Nanomedicine. 2009 Mar;5(1):42-5. doi: 10.1016/j.nano.2008.06.007. Epub 2008 Sep 9.

PMID:
18783999
12.

Self assembly of amphiphilic C60 fullerene derivatives into nanoscale supramolecular structures.

Partha R, Lackey M, Hirsch A, Casscells SW, Conyers JL.

J Nanobiotechnology. 2007 Aug 2;5:6.

13.

Time-resolved FTIR spectroscopy of the photointermediates involved in fast transient H+ release by proteorhodopsin.

Xiao Y, Partha R, Krebs R, Braiman M.

J Phys Chem B. 2005 Jan 13;109(1):634-41.

PMID:
16851056
14.

New insights into metabolic properties of marine bacteria encoding proteorhodopsins.

Sabehi G, Loy A, Jung KH, Partha R, Spudich JL, Isaacson T, Hirschberg J, Wagner M, Béjà O.

PLoS Biol. 2005 Aug;3(8):e273. Epub 2005 Jul 19.

15.

Weakened coupling of conserved arginine to the proteorhodopsin chromophore and its counterion implies structural differences from bacteriorhodopsin.

Partha R, Krebs R, Caterino TL, Braiman MS.

Biochim Biophys Acta. 2005 Jun 1;1708(1):6-12. Epub 2005 Jan 5.

16.

Detection of fast light-activated H+ release and M intermediate formation from proteorhodopsin.

Krebs RA, Alexiev U, Partha R, DeVita AM, Braiman MS.

BMC Physiol. 2002 Apr 9;2:5.

Supplemental Content

Loading ...
Support Center